Sustanon's four esters: what the blend changes and what it doesn't
Sustanon combines four testosterone esters. Its release profile matters, but ingredient count doesn't establish better symptoms, performance or safety.
Read articleFor informational and research purposes only.
Research, explained. Explore peptides, supplements, hormone health, longevity and red light therapy with clear, practical breakdowns of what the studies actually tell us.
Find a topic you’re curious about and take a closer look.
Sustanon combines four testosterone esters. Its release profile matters, but ingredient count doesn't establish better symptoms, performance or safety.
Read articleLonger zenagamtide studies are testing durable weight change, withdrawal and cardiovascular events. Each design answers a different patient question.
Read articleWhat an IGF-1 rise can tell you—and why CJC-1295 fat-loss and muscle claims need direct tissue and functional evidence.
Read articleBody fat, lean tissue and strength are different outcomes. Explore direct sermorelin studies and what a scan can—and cannot—show about recomposition.
Read articleGHRP-2 increased food intake in small controlled human experiments. The longer studies tell a more limited story about weight, nutrition and muscle.
Read articleSmall human studies found brief changes in heart pumping after hexarelin. Learn what those findings mean alongside mixed rodent results and unanswered clinical questions.
Read articleHexarelin's repeated-response experiments show partial, reversible GH attenuation under some conditions. They do not establish an optimal cycle or lasting health benefit.
Read articlePassionflower trials range from surgery to persistent anxiety. Their findings depend on the setting, comparator and whether symptoms or biomarkers improved.
Read articleCollagen form changes the question: native type II collagen, hydrolyzed peptides, joint symptoms and range of motion.
Read articleBoswellia trials test specific extracts. Compare standardization, daily amounts, symptoms and biological markers without turning promising results into repair claims.
Read articlePQQ trials have measured mitochondrial signals, exercise, strength and cognition. Those outcomes tell different stories about the supplement's potential.
Read articlePemvidutide's MRI substudy reported a favorable lean-loss share. Learn what that percentage means and why muscle strength needs separate evidence.
Read article482–493 of 600 articles